Inovio Pharmaceuticals, Inc.
INO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$107,254 | -$135,117 | -$279,818 | -$303,659 |
| Dep. & Amort. | $3,130 | $3,504 | $5,496 | $4,731 |
| Deferred Tax | $0 | -$32 | $4,030 | $0 |
| Stock-Based Comp. | $6,595 | $11,072 | $22,555 | $26,337 |
| Change in WC | -$2,665 | -$10,260 | $19,834 | $50,351 |
| Other Non-Cash | -$3,883 | $6,468 | $11,687 | $6,531 |
| Operating Cash Flow | -$104,077 | -$124,366 | -$216,215 | -$215,709 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$321 | -$969 | -$1,231 |
| Net Acquisitions | $0 | $6,219 | -$2,000 | $0 |
| Inv. Purchases | -$54,138 | -$203,475 | -$248,529 | -$348,953 |
| Inv. Sales/Matur. | $158,638 | $284,933 | $361,084 | $174,840 |
| Other Inv. Act. | -$429 | $0 | $0 | $0 |
| Investing Cash Flow | $104,071 | $87,356 | $109,586 | -$175,344 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$16,415 | $0 | $0 | $0 |
| Stock Issued | $36,033 | $5,462 | $82,955 | $209,441 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $31,857 | -$467 | -$1,115 | $2,057 |
| Financing Cash Flow | $51,476 | $4,995 | $81,841 | $211,499 |
| Forex Effect | $32 | -$4 | -$26 | -$30 |
| Net Chg. in Cash | $51,502 | -$32,018 | -$24,814 | -$179,584 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,311 | $46,329 | $71,144 | $250,728 |
| End Cash | $65,813 | $14,311 | $46,329 | $71,144 |
| Free Cash Flow | -$104,564 | -$124,686 | -$217,185 | -$216,940 |